APP and Alzheimer disease: Using postmortem brain samples from AD individuals and transgenic cells overexpressing APP mutations, Sheng and colleagues observed that the protein content of the critical regulators of mitochondrial biogenesis, PGC-1α, NRF1, NRF2, and TFAM, was significantly decreased in the AD milieu [120].